Atlas Trials

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)

Clinical trial NCT04383275 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04383275
Sponsor
Fudan University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-05-20
Primary completion
2031-07-06
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.